About Cleveland Clinic Neurological Institute Mellen Center
"Cleveland Clinic is one of the largest and most respected hospitals in the country. Our mission is to provide better care of the sick, investigation into their problems, and further education of those who serve. Learn more about our leadership, vision, values and model of healthcare. Every life deserves world class care. Call or visit our website for appointment information."
Clinical Trials at Cleveland Clinic Neurological Institute Mellen Center
During the past decade, Cleveland Clinic Neurological Institute Mellen Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Neurological Institute Mellen Center"
#1 collaborator was "The Kelvin and Eleanor Smith Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Cleveland Clinic Neurological Institute Mellen Center
According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Neurological Institute Mellen Center" are
"Multiple Sclerosis" (3 trials), "Ambulation Difficulty" (1 trials), "Gait Disorders, Neurologic" (1 trials), "Multiple Sclerosis (MS)" (1 trials) and "Progressive Multiple Sclerosis (PMS)" (1 trials). Many other conditions were trialed in "Cleveland Clinic Neurological Institute Mellen Center" in a lesser frequency.
Clinical Trials Intervention Types at Cleveland Clinic Neurological Institute Mellen Center
Most popular intervention types in "Cleveland Clinic Neurological Institute Mellen Center" are "Drug" (4 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (2 trials), "Ekso GT™ exoskeleton" (1 trials), "MD1003 100mg capsule" (1 trials), "PLACEBO" (1 trials) and "Plasma exchange" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cleveland Clinic Neurological Institute Mellen Center
The vast majority of trials in "Cleveland Clinic Neurological Institute Mellen Center" are
6 trials for "All" genders.
Clinical Trials Status at Cleveland Clinic Neurological Institute Mellen Center
Currently, there are NaN active trials in "Cleveland Clinic Neurological Institute Mellen Center".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Cleveland Clinic Neurological Institute Mellen Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Cleveland Clinic Neurological Institute Mellen Center, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".